[HTML][HTML] An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic

BY Arman, J Brun, ML Hill, N Zitzmann… - International Journal of …, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has claimed over 7 million lives
worldwide, providing a stark reminder of the importance of pandemic preparedness. Due to …

The potential of anti-coronavirus plant secondary metabolites in COVID-19 drug discovery as an alternative to repurposed drugs: a review

Z Alipour, S Zarezadeh, AA Ghotbi-Ravandi - Planta Medica, 2023 - thieme-connect.com
In early 2020, a global pandemic was announced due to the emergence of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), known to cause COVID-19. Despite …

[HTML][HTML] Efficacy of additional hemoperfusion in hospitalized patients with severe to critical COVID-19 disease

S Chiewroongroj, R Ratanarat, T Naorungroj… - Scientific Reports, 2024 - nature.com
The evidence supporting additional hemoperfusion (HP) with cytokine adsorbents for
improving clinical outcomes in severe to critical coronavirus disease 2019 (COVID-19) …

Understanding COVID-19: An overview of the virus, variants, vaccines, and treatment strategies

A Manzoor, M Maryam - Diagnostics and Therapeutics, 2024 - ojs.luminescience.cn
The outbreak of coronavirus disease 2019 (COVID-19) has greatly impacted society and
health care worldwide. This narrative review provides an in-depth understanding of severe …